Literature DB >> 2635855

Identification of specific binding sites for vasoactive intestinal peptide in rat testis Leydig cells and study of developmental changes.

C Hueso1, M J Carmena, J C Prieto.   

Abstract

The interaction of vasoactive intestinal peptide (VIP) with isolated Leydig cells from rat testis was time- and temperature-dependent, as well as saturable and specific. Scatchard analysis suggested the presence of both high- and low-affinity binding sites with KD values of 1.7 and 43 nM, respectively, and receptor concentrations of 35 and 1394 fmol VIP bound/mg protein in mature (3- to 6-month old) rats. When considering pubertal (45-day old) rats, the affinities were similar but the binding capacities showed considerably lower values (25 and 193 fmol VIP bound/mg protein) indicating that VIP receptors are subject to developmental changes during animal maturation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2635855

Source DB:  PubMed          Journal:  Biochem Int        ISSN: 0158-5231


  4 in total

1.  Expression of VIP and its receptors in the testis of the spotted ray Torpedo marmorata (Risso 1880).

Authors:  Marisa Agnese; Luigi Rosati; Francesco Muriano; Salvatore Valiante; Vincenza Laforgia; Piero Andreuccetti; Marina Prisco
Journal:  J Mol Neurosci       Date:  2012-07-24       Impact factor: 3.444

2.  Peptides of the growth hormone-releasing hormone family : Differential expression in rat testis.

Authors:  B S Monts; P R Breyer; J K Rothrock; O H Pescovitz
Journal:  Endocrine       Date:  1996-02       Impact factor: 3.633

Review 3.  Neuropeptides of the pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide/growth hormone-releasing hormone/secretin family in testis.

Authors:  Min Li; Akira Arimura
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

4.  Pituitary adenylate cyclase activating polypeptide-mediated intracrine signaling in the testicular germ cells.

Authors:  Min Li; Hisayuki Funahashi; Majambu Mbikay; Seiji Shioda; Akira Arimura
Journal:  Endocrine       Date:  2004-02       Impact factor: 3.633

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.